English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech HealthCare & Pharma
Novotech and CNS deal expands CRO services for Biopharma Clients across Asia-Pacific
Oct 19, 2018 07:00 HKT
Biocure Technology, 급성 백혈병 치료제인 CAR-T 세포 치료제의 비임상 시험 결과 발표
Oct 17, 2018 08:00 HKT
NutraFuels Inc., CBD Nutraceutical Manufacturers, Announces a New Product Line of Travel-Size CBD Products for Retailers and Consumers
Oct 16, 2018 16:00 HKT
NutraFuels Inc., Cannabidiol (CBD) Nutraceutical Manufacturers, Prepares Launching CBD Twists and CBD Drink Shots, Two New Single-Dose Options for Consumers
Oct 05, 2018 15:30 HKT
Nexstim Plc Launches Presence in Asia with Distribution Agreement of its SmartFocus(TM) TMS system to Access Hong Kong Market
Oct 03, 2018 20:00 HKT
Malaysian medicinal herb has anti-diabetic properties
Oct 02, 2018 19:30 HKT
安和医疗集团引进海扶刀技术
Sep 27, 2018 17:12 HKT
安和醫療集團引進海扶刀技術
Sep 27, 2018 17:11 HKT
Cornwall Medical Group Introduces HIFU Tumor Therapy System
Sep 27, 2018 17:10 HKT
PreveCeutical Enters into Development Agreement with Asterion Cannabis Inc. to Develop Medicinal Cannabinoid Products
Sep 26, 2018 18:30 HKT
FDA Grants Myelo Therapeutics Orphan Drug Designation for Myelo001 as Treatment for Acute Radiation Syndrome
Sep 25, 2018 18:00 HKT
李氏大藥廠入選「粵港澳大灣區生物科技創新企業50強」
Sep 12, 2018 20:11 HKT
李氏大药厂入选「粤港澳大湾区生物科技创新企业50强」
Sep 12, 2018 20:12 HKT
Cadrock成功攬獲500萬美元投資,目標指向價值350億美元心髒病市場的診療方案研究
Sep 05, 2018 11:00 HKT
Cadrock成功揽获500万美元投资,目标指向价值350亿美元心脏病市场的诊疗方案研究
Sep 05, 2018 11:00 HKT
NANOBIOTIX half year results for the six months ended June 30, 2018
Sep 05, 2018 00:30 HKT
Cadrock Secures US$5m for Therapy Targeting $35 billion Heart Disease Market
Sep 04, 2018 09:00 HKT
NEGTEC announces Crowdfunding Service promoting Regenerative Medicine
Sep 04, 2018 15:00 HKT
NEGTEC, 재생의료 촉진을 지원하기 위한 가상통화의 크라우드 펀딩 포털 사이트 개설
Sep 03, 2018 15:00 HKT
NEGTEC為了支持促進再生醫療 開設使用虛擬貨幣進行眾籌的門戶網站
Sep 03, 2018 15:00 HKT
Next >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: